The results demonstrate that apatinib enhances antitumour efficacy of cytotoxic drugs through promoting cell apoptosis and inhibiting EMT in ESCC cells, suppresses tumour growth and angiogenesis via blocking Ki67 and VEGFR‐2. Here, KDR is linked to esophageal squamous cell carcinoma.